effect overlay
activetrials
Epilepsy
Epilepsy
BHV7000 Refractory Focal Onset Epilepsy 303

A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

HREC: 2024.145
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact:
Funding: Commercial
Epilepsy
Epilepsy
ENIGMA

Use of deep learning to support clinical decision making for resective surgery in drug resistant focal epilepsy

HREC: 2022.355
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Merran Courtney
Funding: Non-Commercial
Epilepsy
Epilepsy
Drug Resistant Epilepsy

Drug Resistant Epilepsy

HREC: 2019.321
Principal Investigator: Prof Patrick Kwan
Coordinator contact:
Funding: Non-Commercial
Epilepsy
Epilepsy
Genetics of Drug Rash in EP

Genetics of Drug Rash in EP

HREC: 2015.073
Principal Investigator: Prof Patrick Kwan
Coordinator contact: Dr Marian Todaro
Funding: Non-Commercial
Epilepsy
Epilepsy
seLECT - SEL004

A Phase 2, Randomised, Controlled Trial of Sodium Selenate as a Disease-modifying Treatment for Chronic Drug-resistant Temporal Lobe Epilepsy 
 

HREC: 2023.153
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Lei Chen
Funding: Non-Commercial